Literature DB >> 22959802

Cutaneous penetration of the topically applied photosensitizer Pc 4 as detected by intravital 2-photon laser scanning microscopy.

Alex Y Huang1, Jay T Myers, Deborah Barkauskas, Scott J Howell, Nancy L Oleinick, Thomas S McCormick, Kevin D Cooper, Elma D Baron, Minh Lam.   

Abstract

The fundamental mechanism of photodynamic therapy (PDT)-induced cell death has been characterized, but early critical PDT events in vivo remain incompletely defined. With the recent development in advanced fluorescence imaging modalities, such as intravital 2-photon laser scanning microscopy (2P-LSM), researchers are now able to investigate and visualize biological processes with high resolution in real time. This powerful imaging technology allows deep tissue visualization with single-cell resolution, thus providing dynamic information on the 3-dimensional architectural makeup of the tissue. The main goal of this study was to determine the cutaneous penetration of a topically applied photosensitizer, the silicon phthalocyanine Pc 4, into the skin of live animals and to assess the effective absorption of Pc 4 through the skin barrier. Our 2P-LSM images indicate that Pc 4 penetrates to the epidermal/dermal junction of mouse skin. The data also indicate that the degree of Pc 4 absorption is dose dependent. These findings represent initial steps that may help in improving the clinical utilization of topical Pc 4-PDT. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22959802      PMCID: PMC3438456          DOI: 10.1016/j.pdpdt.2012.01.007

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  18 in total

1.  Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial.

Authors:  I Wang; N Bendsoe; C A Klinteberg; A M Enejder; S Andersson-Engels; S Svanberg; K Svanberg
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

2.  Two-photon imaging of lymphocyte motility and antigen response in intact lymph node.

Authors:  Mark J Miller; Sindy H Wei; Ian Parker; Michael D Cahalan
Journal:  Science       Date:  2002-05-16       Impact factor: 47.728

Review 3.  Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer.

Authors:  S H Ibbotson
Journal:  Br J Dermatol       Date:  2002-02       Impact factor: 9.302

Review 4.  An update on photodynamic therapy applications.

Authors:  Thomas J Dougherty
Journal:  J Clin Laser Med Surg       Date:  2002-02

Review 5.  Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy.

Authors:  M Lam; A H Hsia; Y Liu; M Guo; A R Swick; J C Berlin; T S McCormick; M E Kenney; N L Oleinick; K D Cooper; E D Baron
Journal:  Clin Exp Dermatol       Date:  2011-05-30       Impact factor: 3.470

Review 6.  Photodynamic therapy in oncology.

Authors:  C H Sibata; V C Colussi; N L Oleinick; T J Kinsella
Journal:  Expert Opin Pharmacother       Date:  2001-06       Impact factor: 3.889

7.  Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques.

Authors:  Robert Bissonnette; Jean-François Tremblay; Petras Juzenas; Michèle Boushira; Harvey Lui
Journal:  J Invest Dermatol       Date:  2002-07       Impact factor: 8.551

Review 8.  The role of apoptosis in response to photodynamic therapy: what, where, why, and how.

Authors:  Nancy L Oleinick; Rachel L Morris; Irina Belichenko
Journal:  Photochem Photobiol Sci       Date:  2002-01       Impact factor: 3.982

Review 9.  Non-oncologic indications for ALA-PDT.

Authors:  R-M Szeimies; M Landthaler; S Karrer
Journal:  J Dermatolog Treat       Date:  2002       Impact factor: 3.359

10.  Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma.

Authors:  Esther A Coors; Peter von den Driesch
Journal:  J Am Acad Dermatol       Date:  2004-03       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.